SafetyNet for RUA to Launch June 15, 2020

After several months of working with multiple stakeholder groups, we are pleased to announce the launch of the new Radiation Use Authorization (RUA) online system in SafetyNet. This new system will replace the existing paper and email process used for review of non-clinical use of radiation in research and currently managed by UCLA Environment, Health & Safety (EH&S). Our expectation is that this new system … Read More

Office of Research Administration (ORA) 2019-20 Winter Holiday Closure

The Office of Research Administration (ORA) will observe UCLA’s 2019-20 Winter Holiday Closure. ORA will be closed beginning Saturday, December 21, 2019 and will reopen on Thursday, January 2, 2020. Please be advised that the Chancellor’s Animal Research Committee (ARC), Institutional Biosafety Committee (IBC), and Medical Radiation Safety Committee (MRSC) / Radioactive Drug Research Committee (RDRC) will not conduct business during … Read More

IMPORTANT ANNOUNCEMENT: MRSC/RDRC Continuing Review

The following announcement is shared with you on behalf of the Medical Radiation Safety Committee (MRSC) and Radioactive Drug Research Committee (RDRC): Continuing Review: As mentioned during the launch of the New SafetyNet system for the MRSC/RDRC, effective January 2, 2019, all approved MRSC/RDRC submissions, including those migrated into the new system, will be subject to continuing review (CR). CR … Read More

Office of Research Administration (ORA) 2018-19 Winter Holiday Closure

The Office Research Administration (ORA) will observe UCLA’s 2018-19 Winter Holiday Closure. ORA will be closed beginning Saturday, December 22, 2018 and will reopen on Wednesday, January 2, 2019. Please be advised that the Chancellor’s Animal Research Committee (ARC), Institutional Biosafety Committee (IBC), and Medical Radiation Safety Committee (MRSC) / Radioactive Drug Research Committee (RDRC) will not conduct business during the … Read More

New MRSC/RDRC System (SafetyNet) Launch

The following announcements are shared with you on behalf of the Medical Radiation Safety Committee (MRSC) and Radioactive Drug Research Committee (RDRC): New Online System (SafetyNet) After several months of working with multiple stakeholder groups, we are pleased to announce the launch of the new MRSC/RDRC online system in SafetyNet. This system will replace section 8.11 in webIRB and the review … Read More

Radiation Safety Committee (RSC)

The responsibility for ensuring the safe operation of a radiation safety program belongs to the Radiation Safety Committees (RSC). At UCLA, the RSC and the four subcommittees; the Academic Radiation Safety Committee (ARSC), the Clinical Operations Radiation Committee (CORSC), the Medical Radiation Safety Committee (MRSC), and the Radioactive Drug Research Committee (RDRC), are responsible for the policies and procedures pertaining to the use of radiation.

Radioactive Drug Research Committee (RDRC)

The UCLA Radioactive Drug Research Committee (RDRC) operates under the provisions of 21 CFR 361.1 and is responsible for the evaluation of all proposals that involve the use of radioactive drugs in humans without an IND when the drug is administered under the following conditions: The research is considered basic science research and is done for the purpose of advancing scientific knowledge.

Medical Radiation Safety Committee (MRSC)

The UCLA MRSC is responsible for the evaluation of all proposals that involve radiological procedures in medical research at UCLA. The MRSC ensures that the University is in compliance with the policies and procedures outlined in the California Code of Regulations, Title 17 §30100 and conditions of UCLA’s Radioactive Materials license, #1335-19.